Effect of molybdenum on reproductive function of male mice treated with busulfan.
Busulfan
Infertility
Molybdenum
Mouse
Testis
Journal
Theriogenology
ISSN: 1879-3231
Titre abrégé: Theriogenology
Pays: United States
ID NLM: 0421510
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
17
04
2018
revised:
27
11
2018
accepted:
01
12
2018
pubmed:
12
12
2018
medline:
12
2
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
Infertility is a serious public health problem worldwide. Molybdenum (Mo) plays an important role in maintaining normal metabolism. To explore the therapeutic efficacy of molybdenum (Mo) on male infertility, 90 mice were randomly divided into control, busulfan and busulfan + Mo groups. The male mice in the busulfan and busulfan + Mo groups were exposed to busulfan (20 mg/kg body weight) with a single intraperitoneal injection to establish the infertility model. The sterile mice were successfully obtained 30 days after busulfan exposure. Then, the male mice in the busulfan + Mo group were given drinking water containing 20 mg/L Mo continuously for 42 days. At 72 Day after treatment, 30 mice in the three groups were tested for various indices, and 60 mice were mated with females in spontaneous estrus. Mo significantly reversed the thinner seminiferous tubules and disappeared tubule and germ cells. Mo also normalized previously abnormal levels of testosterone, estradiol, luteinizing hormone, superoxide dismutase, lactate dehydrogenase, malondialdehyde. Furthermore, expression levels expression of Bax, Bcl-2, caspase-3 and caspase-9 returned to control levels; and finally, Mo-treated sterile mice obtained offspring with normal number and gender ratio. These results suggested that Mo at 20 mg/L had a significant therapeutic effect on reproductive dysfunction in sterile mice. Its mechanism could via repair of damaged testicular structures, regulation of abnormal reproductive hormone levels, decreased oxidative stress or and resistance to cell apoptosis. Mo may be a new candidate medicine for treatment of male infertility.
Identifiants
pubmed: 30530157
pii: S0093-691X(18)31087-2
doi: 10.1016/j.theriogenology.2018.12.002
pii:
doi:
Substances chimiques
Gonadal Steroid Hormones
0
Trace Elements
0
Molybdenum
81AH48963U
Busulfan
G1LN9045DK
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-54Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.